TSC1
TSC2
结节性硬化
遗传学
外显子
基因
无义突变
种系突变
错义突变
移码突变
突变
生物
医学
病理
PI3K/AKT/mTOR通路
细胞凋亡
作者
Yokihiko Yamashita,Jiro Ono,Shintaro Okada,Mari Wataya‐Kaneda,Kunihiko Yoshikawa,Masae Nishizawa,Youko Hirayama,Etuko Kobayashi,Kuniaki Seyama,Okio Hino
出处
期刊:American journal of medical genetics
[Wiley]
日期:2000-01-17
卷期号:90 (2): 123-123
被引量:4
标识
DOI:10.1002/(sici)1096-8628(20000117)90:2<123::aid-ajmg7>3.3.co;2-c
摘要
Twenty-seven Japanese patients with the tuberous sclerosis complex (TSC), consisting of 23 sporadic and 4 familial cases, were tested for mutations in the TSC1 and TSC2 genes, using single-strand conformational polymorphism analysis and direct sequencing. Four possible pathogenic mutations were found in the TSC1 gene, including three frame shifts and a nonsense mutation in a familial case. All mutations were expected to result in a truncated hamartin gene product. The TSC2 gene analysis identified six possible pathogenic mutations only in the sporadic cases, including two frame shifts, one in-frame deletion, and three missense mutations. Two of the TSC2 mutations were expected to result in a truncated tuberin gene product. These results of the Japanese TSC patients were compatible with the reports from Europe and the United States, i.e., (1) TSC1 mutations are rarer in sporadic cases than in familial cases, (2) substantial numbers of sporadic cases arise from mutations in the TSC2 gene, and (3) mutations of the TSC1 gene may cause premature truncation of hamartin. Am. J. Med. Genet. 90:123–126, 2000 © 2000 Wiley-Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI